Patents by Inventor Kieran James Hyland

Kieran James Hyland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11273271
    Abstract: In one aspect, embodiments of the present invention provide an aerosolization device for ensuring proper delivery of an aerosolized medication to a user's respiratory system. The aerosolization device may include a conduit, an aerosol generator, a restrictor disposed within the conduit, and an indicator mechanism. The conduit may include a mouthpiece end by which a user may cause inspiratory flow through the conduit. The aerosol generator may include a vibratable mesh. The restrictor may define a plurality of apertures disposed along an outer periphery of the restrictor configured to provide an increase in pressure differential that varies with an inspiratory flow rate within the conduit and to provide a relatively laminar flow downstream of the restrictor compared to upstream of the restrictor. The indicator mechanism may indicate to a user a state of a parameter of the inspiratory flow relative to a predefined desired range.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: March 15, 2022
    Assignee: Aerami Therapeutics, Inc.
    Inventors: Jim Fink, Lisa Molloy, Ronan MacLoughlin, Claire Elizabeth Lillis, Michael Joseph Casey, John Matthew Mullins, Kieran James Hyland, Joseph Martin Grehan
  • Publication number: 20210178088
    Abstract: Embodiments provide aerosolization device for providing aerosolized medicament to user. The aerosolization device includes conduit, aerosol generator, fluid receiving chamber, restrictor within the conduit, and indicator mechanism. Conduit has an inner wall and a mouthpiece end for causing an inspiratory flow. Aerosol generator includes a vibratable mesh laterally offset from the inner wall. Fluid receiving chamber receives liquid medicament. At least a portion of chamber is tapered such that liquid medicament is directed onto vibratable mesh for aerosolization. Restrictor defines a plurality of apertures that provide increases in pressure differential that vary with inspiratory flow rate within conduit and provide relatively laminar flow downstream of restrictor. Indicator mechanism indicates a state of flow parameters relative to a predefined range. Aerosol generator is configured to aerosolize at least a portion of liquid medicament only when flow parameters of the inspiratory flow are within range.
    Type: Application
    Filed: December 3, 2020
    Publication date: June 17, 2021
    Inventors: Jim Fink, Lisa Molloy, Ronan MacLoughlin, Claire Elizabeth Lillis, Michael Joseph Casey, John Matthew Mullins, Kieran James Hyland, Joseph Martin Grehan, Niall Scott Smith
  • Patent number: 10857313
    Abstract: Embodiments provide aerosolization device for providing aerosolized medicament to user. The aerosolization device includes conduit, aerosol generator, fluid receiving chamber, restrictor within the conduit, and indicator mechanism. Conduit has an inner wall and a mouthpiece end for causing an inspiratory flow. Aerosol generator includes a vibratable mesh laterally offset from the inner wall. Fluid receiving chamber receives liquid medicament. At least a portion of chamber is tapered such that liquid medicament is directed onto vibratable mesh for aerosolization. Restrictor defines a plurality of apertures that provide increases in pressure differential that vary with inspiratory flow rate within conduit and provide relatively laminar flow downstream of restrictor. Indicator mechanism indicates a state of flow parameters relative to a predefined range. Aerosol generator is configured to aerosolize at least a portion of liquid medicament only when flow parameters of the inspiratory flow are within range.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: December 8, 2020
    Assignee: Aerami Therapeutics, Inc.
    Inventors: Jim Fink, Lisa Molloy, Ronan MacLoughlin, Claire Elizabeth Lillis, Michael Joseph Casey, John Matthew Mullins, Kieran James Hyland, Joseph Martin Grehan, Niall Scott Smith
  • Publication number: 20180021530
    Abstract: In one aspect, embodiments of the present invention provide an aerosolization device for ensuring proper delivery of an aerosolized medication to a user's respiratory system. The aerosolization device may include a conduit, an aerosol generator, a restrictor disposed within the conduit, and an indicator mechanism. The conduit may include a mouthpiece end by which a user may cause inspiratory flow through the conduit. The aerosol generator may include a vibratable mesh. The restrictor may define a plurality of apertures disposed along an outer periphery of the restrictor configured to provide an increase in pressure differential that varies with an inspiratory flow rate within the conduit and to provide a relatively laminar flow downstream of the restrictor compared to upstream of the restrictor. The indicator mechanism may indicate to a user a state of a parameter of the inspiratory flow relative to a predefined desired range.
    Type: Application
    Filed: August 7, 2017
    Publication date: January 25, 2018
    Applicant: Dance Biopharm Inc.
    Inventors: Jim Fink, Lisa Molloy, Ronan McLaughlin, Claire Elizabeth Lillis, Michael Joseph Casey, John Matthew Mullins, Kieran James Hyland, Joseph Martin Grehan
  • Publication number: 20160001019
    Abstract: Embodiments provide aerosolization device for providing aerosolized medicament to user. The aerosolization device includes conduit, aerosol generator, fluid receiving chamber, restrictor within the conduit, and indicator mechanism. Conduit has an inner wall and a mouthpiece end for causing an inspiratory flow. Aerosol generator includes a vibratable mesh laterally offset from the inner wall. Fluid receiving chamber receives liquid medicament. At least a portion of chamber is tapered such that liquid medicament is directed onto vibratable mesh for aerosolization. Restrictor defines a plurality of apertures that provide increases in pressure differential that vary with inspiratory flow rate within conduit and provide relatively laminar flow downstream of restrictor. Indicator mechanism indicates a state of flow parameters relative to a predefined range. Aerosol generator is configured to aerosolize at least a portion of liquid medicament only when flow parameters of the inspiratory flow are within range.
    Type: Application
    Filed: June 18, 2015
    Publication date: January 7, 2016
    Inventors: Jim Fink, Lisa Molloy, Ronan MacLoughlin, Claire Elizabeth Lillis, Michael Joseph Casey, John Matthew Mullins, Kieran James Hyland, Joesph Martin Grehan, Niall Scott Smith
  • Publication number: 20160001018
    Abstract: In one aspect, embodiments of the present invention provide an aerosolization device for ensuring proper delivery of an aerosolized medication to a user's respiratory system. The aerosolization device may include a conduit, an aerosol generator, a restrictor disposed within the conduit, and an indicator mechanism. The conduit may include a mouthpiece end by which a user may cause inspiratory flow through the conduit. The aerosol generator may include a vibratable mesh. The restrictor may define a plurality of apertures disposed along an outer periphery of the restrictor configured to provide an increase in pressure differential that varies with an inspiratory flow rate within the conduit and to provide a relatively laminar flow downstream of the restrictor compared to upstream of the restrictor. The indicator mechanism may indicate to a user a state of a parameter of the inspiratory flow relative to a predefined desired range.
    Type: Application
    Filed: June 18, 2015
    Publication date: January 7, 2016
    Inventors: Jim Fink, Lisa Molloy, Ronan MacLoughlin, Claire Elizabeth Lillis, Michael Joseph Casey, John Matthew Mullins, Kieran James Hyland, Joesph Martin Grehan